Dr. Joe Schlecht isn't afraid of MACRA, although he knows the design of the new Medicare payment system will be challenging for small practices like his. “Most primary-care physicians are still practicing like they did 10 years ago. They don't even know how to spell MACRA,” he said.
The decadelong movement to combat medical errors in hospitals and other healthcare settings has increased demand for specialists who can lead quality and safety improvement projects. New graduate programs are teaching mid-career professionals those leadership skills.
With a median annual compensation of $555,000, orthopedic surgeons topped the highest-paid list this year among the 23 medical specialties in Modern Healthcare's 23rd annual Physician Compensation Survey.
Presumptive GOP presidential nominee Donald Trump is nothing like the party's previous nominees, so it isn't surprising that the GOP health policy platform only days ahead of the convention remains largely unknown—very unlike 2012 or 2008.
Dr. Theodore Strange and his 60 physician colleagues at the University Physicians Group in New York City will soon be hospital-employed again. Across the country, physician groups are going through the same deliberate exercises that led Strange and partners to cast their lot with a bigger system.
A recently filed lawsuit alleging that a faulty electronic health record system caused patient harm may be among the first in a wave of such cases, even though most experts say the latest EHR systems are better designed than older models.
Demands for constant upgrades to already-installed electronic health record systems are slowing investment in other important digital technologies like telehealth, remote patient monitoring and online billing.
The CMS says it's well on its way to dragging hospital systems into the brave new world of risk-based contracting. The systems say, not really.
Federally qualified health centers that serve mostly poor and low-income families in distressed or rural communities have always had a tough time recruiting physicians. And now, it's getting even harder.
Drugmakers are making increased use of consumer coupons, which are designed to thwart the high copays used by pharmacy benefit managers and insurers to channel consumers to less-costly generic drugs.
Are the drugs excluded from formularies by pharmacy benefits managers really no better than what's available at a cheaper price?
Patently perturbed: Trans-Pacific Partnership trade deal raises fears about drug patent periods, higher costs
Multilateral trade deals—such as the Trans-Pacific Partnership touted by President Barack Obama on his recent trip through Asia—are usually of little concern or consequence to healthcare stakeholders. But the TPP could affect pharmaceutical pricing around the globe.